Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Ou connectez-vous avec votre réseau social favori

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Cellulis

Cellulis_logo
6
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Cellulis focuses on developing technologies for cell cryopreservation and cell therapy markets. The company boasts global granted patents which cover disruptive and innovative solutions within the booming cell therapy market.

Santoña, Cantabria, Spain

Send a message

Anglais

Cellulis

Anglais

Cellulis (meaning "for the cells" in Latin) is a young SME company with an amazing success track for approved global patents that cover game changing disruptive enabling technologies in the field of freezing and thawing cells within the cell therapy market. Our technologies provide innovative solutions to improve and standardize the entire cryopreservation process that has been highly conserved since the very first discovery of cryoprotectants in 1949. Much has been...

See more

Cellulis (meaning "for the cells" in Latin) is a young SME company with an amazing success track for approved global patents that cover game changing disruptive enabling technologies in the field of freezing and thawing cells within the cell therapy market. Our technologies provide innovative solutions to improve and standardize the entire cryopreservation process that has been highly conserved since the very first discovery of cryoprotectants in 1949. Much has been done about improving chemical freezing formulations but the current obsolete methodological approaches to the cryopreservation process incurs a great lack of standardization.

Freezing and thawing cells correctly require several processes that need to be performed with care to avoid cell damage. Cells are currently thawed using warm water baths followed by the elimination of the toxic cryoprotectant. The inadequate performance and lack of uniformity of these costly protocols infers an undesirable variability on the cellular product jeopardizing therapeutic efficacy and it poses a serious threat in current clinical settings.

Our Limbo™ technology is unique in the sense that for the first time it introduces simple enclosed mechanisms that assure the correct standardization of freezing and thawing processes, making the whole process operator independent. We are pioneers at offering a final product formulation for the cell therapy market at the same time than avoiding important costs associated to current protocols.

  • 1

    Like

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1012 Entities

Communities